Joachim von Roy

Phytomedics, Inc. discovers, develops, and manufactures botanical therapeutics using proprietary platform technologies. The company was founded in December 1996 by Ilya Raskin and is headquartered in Jamesburg, NJ.

CoDa Therapeutics (NZ) Ltd. develops and markets biopharmaceutical products. The company was founded by David Becker, Colin Green, Bradford J, Duft, and Howard E. Greene and on December 9, 2003 and is headquartered in Auckland, New Zealand.

AgriGenesis Biosciences Ltd. focused on commercial physical and biological research. The company was headquartered in Auckland, new Zealand.

Part of AgResearch Ltd., Orico Ltd. engages in the research and development of biotechnology and muscle growth therapeutics in livestock. The company is based in Dunedin, New Zealand.

Part of AgResearch Ltd., Paraco Ltd. engages in the research and development of parasite technology for sheep. The company is based in Hamilton, New Zealand. Paraco was acquired by AgResearch Ltd. on August 05, 2008.

EnCoate Holdings Ltd. develops food-grade biopolymer technologies. The company was founded in 2003 and is headquartered in Lincoln, New Zealand.

Vital Food Processors Ltd. manufactures and produces kiwifruit based food products. Its brands include Kiwi Crush and Phloe Bowel Health. The company was founded by Michael Anthony Hollier and Bruce William Donaldson in 1991 and is headquartered in Auckland, New Zealand.

Biomatters Ltd. engages in the design of bioinformatics software for molecular biologists and biochemists. It specializes in software development, biotechnology, bioinformatics, sequence analysis, next-generation sequencing, genomics, DNA sequence alignment, assembly and analysis. The firm's products include Geneious, Genome and Melanoma. The company was founded by Daniel Batten, Alexei J. Drummond, Athena Ferreira and Julio Ferreira in 2003 and is headquartered in Auckland, New Zealand.

Keraplast Manufacturing provides personal care products in nutritional and medical areas. It builds blocks at a cellular level, giving the human body structure and order and also develops healthy tissues, including skin, hair and nails. The company is headquartered in Lincoln, New Zealand.

CuroNZ Ltd. is a clinical stage neurotherapeutics company based in Wellsford, New Zealand. The New Zealander company's vision is to transform the quality of life for severely neurologically affected children and adult patients. CuroNZ Ltd. focuses on developing a body and mind boosting drug therapy using a modified naturally occurring molecule called nrp2945. This molecule controls seizure activity and improves comorbidities in patients diagnosed with epileptic encephalopathy syndromes like Lennox-Gastaut syndrome and drug-resistant temporal lobe epilepsy. CuroNZ's peptide drug, nrp2945, has a minimal adverse event profile and is administered through subcutaneous injections every other day. The company has conducted successful phase I safety trials in healthy volunteers and a small phase II trial in patients with absence epilepsy.

Proacta Therapeutics Ltd. develops cancer drugs which target physiological attributes of tumors. The company was founded in 2001 and is headquartered in Auckland, New Zealand.